Surgical treatment of gallbladder carcinoma: a critical review

Updates in Surgery

Volumn 67, Issue 4, 2015, Pages 339-351

  Kakaei, Farzad ^a   Beheshtirouy, Samad ^a   Nejatollahi, Seyed Mohammadreza ^b   Zarrintan, Sina ^a   Mafi, Mohammad Reza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carcinoma; Cholecystectomy; Gallbladder

Indexed keywords

TUMOR MARKER;

CANCER STAGING; CARCINOMA; CHEMORADIOTHERAPY; CHOLECYSTECTOMY; DIAGNOSTIC IMAGING; GALLBLADDER NEOPLASMS; HUMAN; LIVER RESECTION; PALLIATIVE THERAPY; PROCEDURES; RISK FACTOR; TUMOR INVASION;

BIOMARKERS, TUMOR; CARCINOMA; CHEMORADIOTHERAPY; CHOLECYSTECTOMY; DIAGNOSTIC IMAGING; GALLBLADDER NEOPLASMS; HEPATECTOMY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; RISK FACTORS;

EID: 84950252315     PISSN: 2038131X     EISSN: 20383312     Source Type: Journal    
DOI: 10.1007/s13304-015-0328-x     Document Type: Review

References (76)

1. American Cancer Society (2013) Cancer facts and figures 2013. Atlanta, American Cancer Society. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf
2. Shirai Y, Yoshida K, Tsukada K et al (1992) Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 215(4):326–331
3. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, La Vecchia C (2009) Epidemiology of biliary tract cancers: an update. Ann Oncol 20:146–159
4. Barbhuiya M, Singh T, Gupta S, Shrivastav B, Tiwari P (2009) Incidence of gall bladder cancer in rural and semiurban population of north central India: a first insight. Internet J Epidemiol 7(2):1820–2155
5. Andia KM, Gederlini GA, Ferreccio RC (2006) Gallbladder cancer: trend and risk distribution in Chile. Rev Med Chil 134:565–574
6. Nandakumar A, Gupta PC, Gangadharan P, Visweswara RN, Parkin DM (2005) Geographic Pathology revisited: development of an atlas of cancer in India. Int J Cancer 116:740–754
7. Levi F, Lucchini F, Negri E, La Vecchia C (2003) The recent decline in gallbladder cancer mortality in Europe. Eur J Cancer Prev 12:265–267
8. Pilgrim CHC, Groeschl RT, Christians KK, Gamblin TC (2013) Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB 15:839–844
9. Roukounakis N, Manolakopoulos S, Tzourmakliotis D et al (2007) Biliary tract malignancy and abnormal pancreaticobiliary junction in a western population. J Gastroenterol Hepatol 22:1949–1952
10. Matsuba T, Qiu D, Kurosawa M et al (2005) Overview of epidemiology of bile duct and gallbladder cancer focusing on the JACC Study. J Epidemiol 15(Suppl 2):S150–S156
11. Rai A, Mohapatra SC, Shukla HS (2004) A review of association of dietary factors in gallbladder cancer. Indian J Cancer 41:147–151
12. Pandey M (2006) Environmental pollutants in gallbladder carcinogenesis. J Surg Oncol 93(8):640–643
13. Basu S, Singh MK, Singh TB, Bhartiya SK, Singh SP, Shukla VK (2013) Heavy and trace metals in carcinoma of the gallbladder. World J Surg 37(11):2641–2646
14. Rai R, Sharma KL, Misra S, Kumar A (2013) Mittal B.7PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene 530(2):172–177
15. Rai R, Sharma KL, Tiwari S, Misra S, Kumar A, Mittal B (2013) DCC (deleted in colorectal carcinoma) gene variants confer increased susceptibility to gallbladder cancer (Ref. No.: Gene-D-12-01446). Gene 518(2):303–309
16. Srivastava V, Patel B, Kumar M, Shukla M, Pandey M (2013) Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev 14(5):2711–2715
17. Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B (2012) Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One 7(7):e40162
18. Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S (2012) Expression and clinicopathological significance of estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res 5(2):41–47
19. Zhang LQ, Zhang XD, Xu J et al (2013) Potential therapeutic targets for the primary gallbladder carcinoma: estrogen receptors. Asian Pac J Cancer Prev 14(4):2185–2190
20. Yamasaki A, Chijiiwa K, Jimi S et al (2008) Multiseptate gallbladder: report of a case. Hepatogastroenterology 55(84):859–860
21. Cavallaro A, Piccolo G, Panebianco V, Lo Menzo E, Berretta M, Zanghì A, Di Vita M, Cappellani A (2012) Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol 18(30):4019–4027
22. Eil R, Hansen PD, Cassera M et al (2013) Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res 6(4):101–105
23. Adsay V, Jang KT, Roa JC et al (2012) Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol 36(9):1279–1301
24. Roa EI, Muñoz NS, Ibacache SG, Aretxabala UX (2009) Natural history of gallbladder cancer. Analysis of biopsy specimens. Rev Med Chil 137(7):873–880
25. Khangembam BC, Sharma P, Naswa N, Sahoo MK, Kumar R (2013) Solitary breast metastasis from recurrent gallbladder carcinoma simulating a second primary on 18F-FDG PET/CT. Clin Nucl Med 38(11):e433–e434
26. Duffy A, Capanu M, Abou-Alfa GK et al (2008) Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 98(7):485–489
27. D’Hondt M, Lapointe R, Benamira Z et al (2013) Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol 39(6):548–553
28. Hawkins WG, DeMatteo RP, Jarnagin WR et al (2004) Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 11(3):310–315
29. Agarwal AK, Kalayarasan R, Javed A, Gupta N, Nag HH (2013) The role of staging laparoscopy in primary gall bladder cancer—an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer. Ann Surg 258(2):318–323
30. Zhuang PY, Tang ZH, Liu YB, Quan ZW, Zhang YJ (2012) Diagnostic and prognostic role of laparoscopic staging for gallbladder carcinoma. Dig Surg 29(5):367–373
31. Shukla VK, Sharma D, Dixit VK (2006) Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop Gastroenterol 27(4):160–165
32. Srivastava K, Srivastava A, Mittal B (2013) Potential biomarkers in gallbladder cancer: present status and future directions. Biomarkers 18(1):1–9
33. Ritts RE Jr, Nagorney DM, Jacobsen DJ, Talbot RW, Zurawski VR Jr (1994) Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas 9(6):707–716
34. Adachi Y, Iso Y, Moriyama M, Kasai T, Hashimoto H (1998) Increased serum CA19-9 in patients with xanthogranulomatous cholecystitis. Hepatogastroenterology 45(19):77–80
35. Principe A, Del Gaudio M, Grazi GL, Paolucci U, Cavallari A (2003) Mirizzi syndrome with cholecysto-choledocal fistula with a high CA19-9 level mimicking biliary malignancies: a case report. Hepatogastroenterology 50(53):1259–1262
36. Giuliante F, Ardito F, Vellone M, Clemente G, Nuzzo G (2006) Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy. Am J Surg 191(1):114–116
37. Akosa AB, Barker F, Desa L, Benjamin I, Krausz T (1995) Cytologic diagnosis in the management of gallbladder carcinoma. Acta Cytol 39(3):494–498
38. Curcio G, Traina M, Mocciaro F et al (2012) Intraductal aspiration: a promising new tissue-sampling technique for the diagnosis of suspected malignant biliary strictures. Gastrointest Endosc 75(4):798–804
39. American joint committee on cancer: Gallbladder and extrahepatic bile ducts (2010) In: Edge SB, Byrd DR, Compton CC et al (eds) AJCC Cancer staging manual, 7th edn. Springer, New York, pp 211–217
40. Onoyama H, Yamamoto M, Tseng A et al (1995) Extended cholecystectomy for carcinoma of the gallbladder. World J Surg 19:758–763
41. Nevin JE, Moran TJ, Kay S et al (1976) Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer 37:141–148
42. Fong Y, Wagman L, Gonen M et al (2006) Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 243(6):767–771 discussion 771-4
43. Kayahara M, Nagakawa T (2007) Recent trends of gallbladder cancer in Japan. Cancer 10:572–580
44. Miller G, Jarnagin WR (2008) Gallbladder carcinoma. Eur J Surg Oncol 34(3):306–312
45. Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC (2013) Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci 58(9):2455–2462
46. Chatelain D, Fuks D, Farges O, Attencourt C, Pruvot FR, Regimbeau JM (2013) Pathology report assessment of incidental gallbladder carcinoma diagnosed from cholecystectomy specimens: results of a French multicentre survey. Dig Liver Dis 45(12):1056–1060
47. Hari DM, Howard JH, Leung AM, Chui CG, Sim MS, Bilchik AJ (2013) A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate? HPB 15:40–48
48. Downing SR, Cadogan KA, Ortega G, Oyetunji TA, Siram SM, Chang DC, Ahuja N, Leffall LD Jr, Frederick WA (2011) Early-stage gallbladder cancer in the surveillance, epidemiology, and end results database: effect of extended surgical resection. Arch Surg 146(6):734–738
49. Ramos-Font C, Gómez-Rio M, Rodríguez-Fernández A, Jiménez-Heffernan A, Sánchez Sánchez R, Llamas-Elvira JM (2014) Ability of FDG-PET/CT in the detection of gallbladder cancer. J Surg Oncol 109(3):218–224
50. Ogura Y, Mizumoto R, Isaji S, Kusuda T, Matsuda S, Tabata M (1991) Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 15:337–343
51. Goetze TO, Paolucci V (2010) Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc 24(9):2156–2164
52. Chijiiwa K, Nakano K, Ueda J, Noshiro H, Nagai E, Yamaguchi K, Tanaka M (2001) Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg 192(5):600–607
53. Shirai Y, Sakata J, Wakai T, Ohashi T, Hatakeyama K (2012) “Extended” radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations. World J Gastroenterol 18(34):4736–4743
54. Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH (1996) Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 224(5):639–646
55. Fuks D, Regimbeau JM, Pessaux P, Bachellier P, Raventos A, Mantion G, Gigot JF, Chiche L, Pascal G, Azoulay D, Laurent A, Letoublon C, Boleslawski E, Rivoire M, Mabrut JY, Adham M, Le Treut YP, Delpero JR, Navarro F, Ayav A, Boudjema K, Nuzzo G, Scotte M, Farges O (2013) Is port-site resection necessary in the surgical management of gallbladder cancer? J Visc Surg 150(4):277–284
56. Maker AV, Butte JM, Oxenberg J, Kuk D, Gonen M, Fong Y, Dematteo RP, D’Angelica MI, Allen PJ, Jarnagin WR (2012) Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol 19(2):409–417
57. Pawlik TM, Gleisner AL, Vigano L, Kooby DA, Bauer TW, Frilling A, Adams RB, Staley CA, Trindade EN, Schulick RD, Choti MA, Capussotti L (2007) Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 11(11):1478–1486 discussion 1486-7
58. Weber SM, DeMatteo RP, Fong Y et al (2002) Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 235(3):392–399
59. Nagino M, Kamiya J, Nishio H, Ebata T, Arai T, Nimura Y (2006) Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243(3):364–372
60. Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nagino M (2012) Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations. Dig Surg 29(1):23–29
61. Choi BG, Kim CY, Cho SH, Kim HJ, Koh YS, Kim JC, Cho CK, Kim HJ, Hur YH (2013) Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc 84(3):168–177
62. Kondo S, Nimura Y, Hayakawa N et al (2000) Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 87(4):418–422
63. Chijiiwa K, Kai M, Nagano M, Hiyoshi M, Ohuchida J, Kondo K (2007) Outcome of radical surgery for stage IV gallbladder carcinoma. J Hepat Pancreat Surg 14(4):345–350
64. Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Mitsuhashi N, Takeuchi D, Suda K, Yoshioka I, Miyazaki M (2007) Aggressive surgical approach for stage IV gallbladder carcinoma based on Japanese Society of Biliary Surgery classification. J Hepat Pancreat Surg 14(4):358–365
65. Whang EE, Duxbury M, Rocha FG, Zinner MJ (2013) Cancer of the gallbladder and bile ducts. In: Zinner MJ, Ashley SW (eds) Maingot’s abdominal operations, 12th edn. McGraw-Hill, New York, pp 1061–1075
66. Shinmura K, Kaiho T, Yanagisawa S, Okamoto R, Nishimura M, Kobayashi S, Okaniwa A, Nomura S, Tsuchiya S, Miyazaki M (2013) A case of long-term survival after aggressive surgery for stage IV gallbladder carcinoma. Gan Kagaku Ryoho 40(12):1768–1770
67. Romiti A, D’Antonio C, Zullo A, Sarcina I, Di Rocco R, Barucca V, Durante V, Marchetti P (2012) Chemotherapy for the biliary tract cancers: moving toward improved survival time. J Gastrointest Cancer 43(3):396–404
68. Yang R, Wang B, Chen YJ, Li HB, Hu JB, Zou SQ (2013) Efficacy of gemcitabine plus platinum agents for biliary tract cancers: a meta-analysis. Anticancer Drugs 24(8):871–877
69. Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, Shin DB, Kang HJ, Sun JM, Park JO, Park YS, Kang WK, Lim HY (2012) Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 13(2):181–188
70. Moretto R, Raimondo L, De Stefano A, Cella CA, Matano E, De Placido S, Carlomagno C (2013) FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience. Anticancer Drugs 24(9):980–985
71. Glazer ES, Liu P, Abdalla EK, Vauthey JN, Curley SA (2012) Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg 16(9):1666–1671
72. Kim K, Chie EK, Jang JY, Kim SW, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW (2012) Postoperative chemoradiotherapy for gallbladder cancer. Strahlenther Onkol 188(5):388–392
73. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, Bhatia S, Nagorney DM (2009) Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience. Int J Radiat Oncol Biol Phys 75(1):150–155
74. Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H, Haddock MG, Nagorney D (2002) Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52(1):167–175
75. Bonet Beltrán M, Allal AS, Gich I, Solé JM, Carrió I (2012) Is adjuvant radiotherapy needed after curative resection of extrahepatic biliary tract cancers? A systematic review with a meta-analysis of observational studies. Cancer Treat Rev 38(2):111–119
76. Launois B, Maddern G, Tay KH (1999) The Glissonian approach of the hilum. Swiss Surg 5(3):143–146